GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Appropriations History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Appropriations | ₹8,918 Cr | ₹7,955 Cr | ₹9,508 Cr | ₹8,175 Cr | ₹7,300 Cr |
What is the latest Appropriations of GLENMARK PHARMACEUTICALS ?
| Year | Appropriations |
|---|---|
| Mar2026 | ₹8,918 Cr |
| Mar2025 | ₹7,955 Cr |
| Mar2024 | ₹9,508 Cr |
| Mar2023 | ₹8,175 Cr |
| Mar2022 | ₹7,300 Cr |
How is Appropriations of GLENMARK PHARMACEUTICALS Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2026 | ₹8,918 Cr | 12.09 | |
| Mar2025 | ₹7,955 Cr | -16.33 | |
| Mar2024 | ₹9,508 Cr | 16.30 | |
| Mar2023 | ₹8,175 Cr | 12.00 | |
| Mar2022 | ₹7,300 Cr | - | |
Compare Appropriations of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹63,636.1 Cr | -1.7% | 0.6% | 12.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -2.3% | -3.3% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.3% | 16.3% | 44.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 2.8% | -0.5% | 37.1% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -3.1% | -1.2% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -2.9% | -3% | -3.3% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -1.7% |
0.6% |
12.2% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses